Avantax Advisory Services, Inc. Vbi Vaccines Inc Transaction History

Avantax Advisory Services, Inc.

  • $15.6 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023
SELL
$0.29 - $0.64 $87 - $192
-300 Reduced 2.91%
10,000 $3,000
Q4 2022

Feb 13, 2023
BUY
$0.38 - $22.5 $114 - $6,750
300 Added 3.0%
10,300 $4,000
Q3 2022

Nov 01, 2022
BUY
$0.73 - $23.4 $7,300 - $234,000
10,000 New
10,000 $7,000

Others Institutions Holding VBIV

# of Institutions
2
Shares Held
688K
Call Options Held
0
Put Options Held
0
View Full List

About VBI Vaccines Inc

VBIV Quotes by TradingView
  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email